Marshall Wace, LLP Abb Vie Inc. Put Options Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $14.6 Million - $16.4 Million	106,000 New	106,000 $16.4 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $3.76 Million - $4.68 Million	28,400 New	28,400 $3.83 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $539,409 - $646,893	-3,900 Reduced 43.33%	5,100 $824,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.21 Million - $1.39 Million	9,000 New	9,000 $1.21 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $61,380 - $67,572	600 New	600 $65,000

3,863

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $307B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.